Les facteurs contribuant à l'observance d'une psychopharmacothérapie chez les adolescents hébergés en centres de réadaptation

Canadian Psychology

Volumn 48, Issue 4, 2007, Pages 211-220

  Laurier, Catherine ^a   Lafortune, Denis ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 38349001080     PISSN: 07085591     EISSN: None     Source Type: Journal    
DOI: 10.1037/cp2007019     Document Type: Article

References (51)

1. Baillargeon, J., Contreras, S., Grady, J. J., Black, S. A., & Murray, O. (2000). Compliance with antidepressant medication among prison inmates with depressive disorders. Psychiatric Services, 51, 1444-1446.
2. Baumann, M., & Trincard, M. (2002). Les attitudes d'autonomie dans l'observance thérapeutique d'une cohorte de consommateurs continus de psychotropes. Encéphale, 28(5 Pt 1), 389-396.
3. Bastiaens, L. (1995). Compliance with pharmacotherapy in adolescents : Effects of patients' and parents' knowledge and attitudes toward treatment. Journal of child and adolescent psychopharmacology, 5, 39-48.
4. Becker, M. H., & Mainman, L. A. (1975). Sociobehavioral Determinants of compliance with health and medical care recommendations. Medical Care, 13, 10-24.
5. Berg, W. E., & Wallace, M. (1987). Effect of treatment setting on social worker's knowledge of psychotropic drugs. Heath and Social Work, 12, 144-152.
6. Bouchard, R. (2002). Psychopharmacologie et prise en charge des adolescents dans les Centres Jeunesse. Mémoire de maîtrise inédit. École de criminologie, Université de Montréal.
7. Bourgeois, J. A. (2005). Compliance with psychiatrie treatment in primary care: Review and strategies. Primary Psychiatry, 12, 40-47.
8. Bowen, J., Fenton, T., & Rappaport, L. (1991). Stimulant medication and attention deficit-hyperactivity disorder. The child's perspective. American Journal of Diseases of Children, 145, 291-295.
9. Bradley, S. S. (2003). The psychology of psychopharmacology triangle: The client, the clinicians and the medication. Social Work in Mental Health, 1, 29-50.
10. Britten, N. (1998). Psychiatry, stigma, and resistance. Psychiatrists need to concentrate on understanding, not simply compliance. British Medical Journal, 5/7(7164), 963-964.
11. Bush, P. J., & Iannotti, R.J. (1990). A Children's Health Belief Model. Medical Care, 28, 69-86.
12. Chappuy, H., Tréluyer, J.-M., Gary, A., Pons, G., & Chéron, G. (2005). Observance médicamenteuse chez l'enfant. Archives de pédiatrie, 12, 921-923.
13. Conrad, P. (1985). The meaning of medications: Another look at compliance. Social Sciences and Medicine, 20, 29-37.
14. Cramer, J. A., & Rosenheck, R. (1998). Compliance with medication regimens for mental and physical disorders. Psychiatric Services, 49, 196-201.
15. Davis, M. S. (1968). Variations in patients' compliance with doctors' advice: An empirical analysis of patterns of communication. American Journal of Public Health & the Nation's Health, 58, 274-288.
16. DiMatteo, M. R. (1994). Enhancing patient adherence to medical recommendations. Journal of the American Medical Association:Jan 5, 271, 79-83.
17. Dixon, L., Weiden, P., Torres, M., & Lehman, A. (1997). Assertive community treatment and medication compliance in the homeless mentally ill. American Journal of Psychiatry, 134, 1302-1304.
18. DosReis, S., Zito, J. M., Safer, D.J., Soeken, K. L., Mitchell, J. W. Jr., & Ellwood, L. C. (2003). Parental perceptions and satisfaction with stimulant medication for attention-deficit hyperactivity disorder. Journal of Developmental and Behavioral Pediatrics, 24, 155-162.
19. Ellis, S., Shumaker, S., Sieber, W., & Rand, C. (2000). Adherence to pharmacological interventions. Current trends and future directions. The Pharmacological Intervention Working Group. Controlled Clinical Trials, 21, 218S-225S.
20. Fawcett, J. (1995). Compliance: Definitions and key issues. Journal of Clinical Psychiatry, 56, 4-8.
21. Gaudet, J., & Chagnon, F. (2003). Étude des besoins prioritaires en matière déprogrammes chez les adolescents au CJMIU. Montréal, QC : Centre Jeunesse de Montréal.
22. Ghaziuddin, N., King, C. A., Hovey, J. D., Zaccagnini, J., & Ghaziuddin, M. (1999). Medication noncompliance in adolescents with psychiatric disorders. Child Psychiatry and Human Development, 30, 103-110.
23. Cordis, L. (1976). Methodologic Issues in the Measurement of Patient Compliance. Dans D. Sackett et R. B. Haynes (Éds.). Compliance with Therapeutic Regimens (p. 51-66). Baltimore, MD: Johns Hopkins University Press.
24. Grasset, F., Bonvin, E., & Pomini, V. (2000). Pharmacothérapie psychotrope, compliance au traitement et observance des prescriptions. Revue médicale de la suisse romande, 120, 137-143.
25. Greenhill, L. L., & Setterberg, S. (1993). Pharmacotherapy of disorders of adolescents, Psychiatric Clinics of North America, 16, 793-814.
26. Hack, S., & Chow, B. (2001). Pediatric psychotropic medication compliance: A literature review and research-based suggestions for improving treatment compliance. Journal of Child and Adolescent Psychopharmacology, 11, 59-67.
27. Haynes, R. B. (1979). Introduction. Dans R. B. Haynes, D. W. Taylor et D. L. Sackett (Éds.), Compliance in Health Care (p. 1-7). Baltimore, MD: Johns Hopkins University Press.
28. Home, R., & Weinman, J. (1999). Patients' beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness. Journal of Psychosomatic Research, 47, 555-567.
29. Korsch, B. M., Gozzi, E. K., & Francis, V. (1968). Gaps in doctor-patient communication. Pediatrics, 42, 855-871.
30. Leo, R. J., Jassal, K., & Bakhai, Y. D. (2005). Nonadherence with psychopharmacologic treatment among psychiatric patients. Primary Psychiatry, 12, 33-39.
31. Lerner, B. H. (1997). From careless consumptives to recalcitrant patients: The historical construction of noncompliance. Social Sdences and Medicine, 45, 1423-1431.
32. Lafortune, D., Laurier, C., & Gagnon, F. (2004). Prévalence et facteurs associés àla prescription de médicaments psychotropes chez les sujets placés en Centre Jeunesse. Revue de psychoéducation, 33, 157-176.
33. McDonald, H. P., Garg, A. X., & Haynes, R. B. (2002). Interventions to enhance patient adherence to medication prescriptions: Scientific review. Journal of the American Medical Association, 288, 2868-2879.
34. Meichenbaum, D., & Turk, D. C. (1987). Facilitating treatment adherence. New York : Plenum Press.
35. Mercier, C. (1989). Le rôle des facteurs subjectifs dans la fidélité à la médication. Revue canadienne de psychiatrie, 34, 662-667.
36. Moline, S., & Frankenberger, W. (2001). Use of stimulant medication for treatment of attention-deficit/hyperactivity disorder: A survey of middle and high school students' attitudes. Psychology in the Schools, 38, 569-584.
37. Morris, M. (1996). Patients' perceptions of psychiatric home care. Archives of Psychiatric Nursing 10, 176-183.
38. Moses, T. (2003). Social workers' perspectives on medicalized treatment of youth. Thèse de doctorat non publiée. Los Angeles, CA : University of California.
39. Pampallona, S., Bollini, P., Tibaldi, G., Kupelnick, B., & Munizza, C. (2002). Patient adherence in the treatment of depression. British Journal of Psychiatry, 180, 104-109.
40. Pauzé, R. 2000. Les soins aux jeunes en difficulté - Volet 1. Portrait des jeunes inscrits àla prise en charge des Centres Jeunesse du Québec et description des services reçus au cours des premiers mois. Sherbrooke, QC : Groupe de recherche sur les inadaptations sociales des enfants. Université de Sherbrooke.
41. Preston, D. L. (2000). La résistance au traitement en milieu correctionnel. Forum. Recherche sur l'actualité correctionnelle, 12, 24-28.
42. Ross, F. M. (1991). Patient compliance - Whose responsibility? Social Sciences and Medicine, 32, 89-94.
43. Scott, C. S., Lore, C., & Owen, R. G. (1992). Increasing medication compliance and peer support among psychiatrically diagnosed students. The Journal of School Health, 62, 478-480.
44. Sher, I., McGinn, L., Sirey, J., & Meyers, B. (2005). Effets of caregivers' perceived stigma and causal beliefs on patients' adherence to antidepressant treatment. Psychiatric Services, 56, 564-569.
45. Sleath, B., Roter, D., Chewning, B., & Svarstad, B. (1999). Asking questions about medication: Analysis of physician-patient interactions and physician perceptions. Medical Care, 37, 1169-1173.
46. Sleator, E. K. (1985). Measurement of compliance. Psychopharmacology Bulletin, 21, 1089-1093.
47. Thiruchelvam, D., Charach, A., & Schachar, R.J. (2001). Moderators and mediators of long-term adherence to stimulant treatment in children with ADHD. Journal of the American Academy of Child and Adolescent Psychiatry, 40, 922-928.
48. Trostle, J. A., (1998). Medical compliance as an ideology. Social Sciences and Medicine, 27, 1299-1308.
49. Van De Geest, S., Renteln-Kruse, W. V., Steeman, E., Degraeve, S., & Abraham, I. L. (1998). Compliance issues with the geriatric population. Nursing Clinics of North America, 33, 467-480.
50. Willey, C., Redding, C., Stafford, J., Garfield, F., Geletko, S., Flanigan, T., Melbourne, K., Mitty, J., & Caro, J.J. (2000). Stages of change for adherence with medication regimens for chronic disease: Development and validation of a measure. Clinical Therapeutics, 22, 858-871.
51. Williams, R. A., Hollis, H. M., & Benoit, K. (1998). Attitudes toward psychiatric medications among incarcerated female adolescents. Journal of the American Academy of Child and Adolescent Psychiatry, 37, 1301-1307.